Prevalence of erythromycin-resistant emm92-type invasive group A streptococcal infections among injection drug users in West Virginia, United States, 2021-23.

Lillie M PowellSoo Jeon ChoiBreanna L HaughtRyan DemkowiczP Rocco LaSalaSlawomir Lukomski

Published in: The Journal of antimicrobial chemotherapy (2023)

Isolates of emm92 type (clonal subtype emm92.0) were associated with iGAS infections in adult IV drug users, but not with paediatric pharyngitis, and were uniformly resistant to erythromycin and clindamycin.

Keyphrases

intensive care unit
emergency department
risk factors
adverse drug
drug induced
young adults
genetic diversity
childhood cancer